$MASI
MASIMO CORP

2013 Q2 Form 10-Q Financial Statement

#000119312513313110 Filed on August 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $137.4M $122.8M
YoY Change 11.93% 8.61%
Cost Of Revenue $46.19M $41.34M
YoY Change 11.72% 14.21%
Gross Profit $91.23M $81.43M
YoY Change 12.03% 5.99%
Gross Profit Margin 66.39% 66.33%
Selling, General & Admin $54.17M $47.65M
YoY Change 13.69% 14.82%
% of Gross Profit 59.38% 58.51%
Research & Development $13.88M $11.11M
YoY Change 24.92% 11.1%
% of Gross Profit 15.21% 13.64%
Depreciation & Amortization $2.800M $2.200M
YoY Change 27.27% 10.0%
% of Gross Profit 3.07% 2.7%
Operating Expenses $68.05M $58.76M
YoY Change 15.82% 14.1%
Operating Profit $23.18M $22.67M
YoY Change 2.24% -10.7%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$238.0K -$462.0K
YoY Change -48.48% -331.0%
Pretax Income $22.94M $22.21M
YoY Change 3.29% -13.24%
Income Tax $8.294M $4.443M
% Of Pretax Income 36.15% 20.0%
Net Earnings $17.04M $17.70M
YoY Change -3.72% -1.75%
Net Earnings / Revenue 12.4% 14.41%
Basic Earnings Per Share $0.30 $0.31
Diluted Earnings Per Share $0.30 $0.30
COMMON SHARES
Basic Shares Outstanding 56.44M shares 57.14M shares
Diluted Shares Outstanding 57.20M shares 58.08M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $78.10M $121.5M
YoY Change -35.72% 15.06%
Cash & Equivalents $78.07M $121.5M
Short-Term Investments
Other Short-Term Assets $3.251M $25.60M
YoY Change -87.3% 25.49%
Inventory $55.72M $45.70M
Prepaid Expenses $12.99M
Receivables $66.97M $64.50M
Other Receivables $7.000M $7.300M
Total Short-Term Assets $236.0M $264.7M
YoY Change -10.84% 14.19%
LONG-TERM ASSETS
Property, Plant & Equipment $23.99M $21.40M
YoY Change 12.1% 40.79%
Goodwill $22.47M
YoY Change
Intangibles $27.99M
YoY Change
Long-Term Investments
YoY Change
Other Assets $7.473M $76.40M
YoY Change -90.22% 8.37%
Total Long-Term Assets $161.2M $116.3M
YoY Change 38.63% 20.89%
TOTAL ASSETS
Total Short-Term Assets $236.0M $264.7M
Total Long-Term Assets $161.2M $116.3M
Total Assets $397.2M $381.0M
YoY Change 4.26% 16.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.62M $22.70M
YoY Change 39.31% 27.53%
Accrued Expenses $15.84M $33.20M
YoY Change -52.28% 37.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $0.00
YoY Change
Total Short-Term Liabilities $92.79M $74.70M
YoY Change 24.22% 18.38%
LONG-TERM LIABILITIES
Long-Term Debt $200.0K $100.0K
YoY Change 100.0% 0.0%
Other Long-Term Liabilities $10.33M $11.10M
YoY Change -6.95% 9.9%
Total Long-Term Liabilities $10.33M $11.20M
YoY Change -7.79% 9.8%
TOTAL LIABILITIES
Total Short-Term Liabilities $92.79M $74.70M
Total Long-Term Liabilities $10.33M $11.20M
Total Liabilities $103.7M $88.80M
YoY Change 16.83% 17.0%
SHAREHOLDERS EQUITY
Retained Earnings $107.8M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $83.45M
YoY Change
Treasury Stock Shares 4.156M shares
Shareholders Equity $293.3M $292.2M
YoY Change
Total Liabilities & Shareholders Equity $397.2M $381.0M
YoY Change 4.26% 16.16%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $17.04M $17.70M
YoY Change -3.72% -1.75%
Depreciation, Depletion And Amortization $2.800M $2.200M
YoY Change 27.27% 10.0%
Cash From Operating Activities $7.300M $8.000M
YoY Change -8.75% -50.62%
INVESTING ACTIVITIES
Capital Expenditures -$3.200M -$3.700M
YoY Change -13.51% 184.62%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$3.200M -$3.600M
YoY Change -11.11% 176.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.300M -11.70M
YoY Change -37.61% -587.5%
NET CHANGE
Cash From Operating Activities 7.300M 8.000M
Cash From Investing Activities -3.200M -3.600M
Cash From Financing Activities -7.300M -11.70M
Net Change In Cash -3.200M -7.300M
YoY Change -56.16% -142.2%
FREE CASH FLOW
Cash From Operating Activities $7.300M $8.000M
Capital Expenditures -$3.200M -$3.700M
Free Cash Flow $10.50M $11.70M
YoY Change -10.26% -33.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57308000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.78
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8368000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3156000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16648000
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
55000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
258783000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27033000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
89539000
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
838000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6700000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25021000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
3542000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
275668000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10103000
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
60000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
273079000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1956000
CY2012Q4 us-gaap Minority Interest
MinorityInterest
2589000
CY2012Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
74361000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
19278000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
375946000
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1504000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71554000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8022000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8587000
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
22363000
CY2012Q4 us-gaap Assets
Assets
375946000
CY2012Q4 us-gaap Liabilities
Liabilities
100278000
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
576000
CY2012Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
57000
CY2012Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5700000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
800000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
219347000
CY2012Q4 us-gaap Goodwill
Goodwill
22824000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27363000
CY2012Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
1600000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67911000
CY2012Q4 us-gaap Inventory Net
InventoryNet
47358000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
17798000
CY2012Q4 us-gaap Us Government Agencies Securities At Carrying Value
USGovernmentAgenciesSecuritiesAtCarryingValue
32000000
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3896000
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4856000
CY2012Q4 us-gaap Cash
Cash
38000000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
12911000
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
24704000
CY2012Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
33600000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
63664000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23924000
CY2012Q4 masi Royalties Receivables
RoyaltiesReceivables
7130000
CY2012Q4 masi Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
52103000
CY2013Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
6000000 shares
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
699000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121517000
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56473471 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56473000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5059000 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.72
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9267000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5588000 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.62
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15843000
CY2013Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
114000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4174000
CY2013Q2 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
2139000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
266000000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11965000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
31623000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2691000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
80000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2059000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
92789000
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
4156000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
19000
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
913000
CY2013Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
53600000
CY2013Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
4282000
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7200000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24020000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
2883000
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
293486000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10328000
CY2013Q2 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
714000
CY2013Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
226000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
293312000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
29000
CY2013Q2 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
19000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1493000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
CY2013Q2 us-gaap Minority Interest
MinorityInterest
174000
CY2013Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
80000
CY2013Q2 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
2720000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
639000
CY2013Q2 us-gaap Contractual Obligation
ContractualObligation
12337000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
107827000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
20453000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
75000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
397229000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
108000
CY2013Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
2463000
CY2013Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
736000
CY2013Q2 us-gaap Liabilities
Liabilities
103743000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2383000
CY2013Q2 us-gaap Deferred Rent Credit
DeferredRentCredit
700000
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
400000
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
372000
CY2013Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
56000
CY2013Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
6200000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Accrued Rent Current And Noncurrent
AccruedRentCurrentAndNoncurrent
800000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
236000000
CY2013Q2 us-gaap Goodwill
Goodwill
22469000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27993000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7473000
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12987000
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
21497000
CY2013Q2 us-gaap Assets
Assets
397229000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78073000
CY2013Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
1800000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66971000
CY2013Q2 us-gaap Inventory Net
InventoryNet
55717000
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21285000
CY2013Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
2500000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
19700000
CY2013Q2 us-gaap Us Government Agencies Securities At Carrying Value
USGovernmentAgenciesSecuritiesAtCarryingValue
35000000
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3251000
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5724000
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
31300000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
17400000
CY2013Q2 us-gaap Cash
Cash
41300000
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
12001000
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28708000
CY2013Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
36800000
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
83454000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23990000
CY2013Q2 masi Royalty Receivable
RoyaltyReceivable
7000000
CY2013Q2 masi Severance Plan Participation Agreements
SeverancePlanParticipationAgreements
3 Agreement
CY2013Q2 masi Royalties Receivables
RoyaltiesReceivables
7000000
CY2013Q2 masi Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
57807000
CY2013Q2 masi Limited Severance Plan Participation Agreements
LimitedSeverancePlanParticipationAgreements
2 Agreement
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
698000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129882000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.373 pure
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58612000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
22.74
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
952000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1200000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31169000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.426 pure
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
1222000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57660000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.008 pure
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6400000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.013 pure
us-gaap Revenues
Revenues
242003000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
33414000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
367000
us-gaap Gross Profit
GrossProfit
160737000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
7150000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
227536000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
23000
us-gaap Profit Loss
ProfitLoss
33534000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1896000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-285000
us-gaap Operating Income Loss
OperatingIncomeLoss
45001000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1220000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
325000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
43957000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-57000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7154000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1044000
us-gaap Net Income Loss
NetIncomeLoss
33471000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-152000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26268000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4842000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
63000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1166000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25983000
us-gaap Inventory Write Down
InventoryWriteDown
533000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
81266000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-319000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26300000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2218000
us-gaap Share Based Compensation
ShareBasedCompensation
7837000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-216000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8365000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
310000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-485000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5410000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13212000
us-gaap Product Warranty Expense
ProductWarrantyExpense
1221000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21615000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1544000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
593000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3973000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-285000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7800000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2100000
us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
100000
us-gaap Operating Expenses
OperatingExpenses
115736000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
94121000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10423000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-339000
masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.12 pure
masi Income Tax Benefit From Exercise Of Stock Options Granted
IncomeTaxBenefitFromExerciseOfStockOptionsGranted
138000
masi Royalty
Royalty
14467000
masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.14 pure
masi Increase Decrease In Royalties Receivable
IncreaseDecreaseInRoyaltiesReceivable
151000
dei Trading Symbol
TradingSymbol
MASI
dei Entity Registrant Name
EntityRegistrantName
MASIMO CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-29
dei Entity Central Index Key
EntityCentralIndexKey
0000937556
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-28
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.362 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.290 pure
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57607000 shares
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
23.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>1. Description of the Company</b></font></p> <!-- xbrl,body --> <p style="PADDING-BOTTOM: 0px; MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Masimo Corporation, or the Company, is a global medical technology company that develops, manufactures and markets noninvasive patient monitoring products. The Company&#x2019;s mission is to improve patient outcomes and reduce cost of care by taking noninvasive monitoring to new sites and applications. The Company invented Masimo Signal Extraction Technology, or Masimo SET<font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">&#xAE;</sup></font>, which provides the capabilities of Measure-Through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. The Company has also developed Masimo rainbow<font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">&#xAE;</sup></font> SET products which monitor multiple blood measurements, including oxygen content, carboxyhemoglobin, methemoglobin and hemoglobin. Additional rainbow<font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">&#xAE;</sup></font> SET measurements that assist clinicians are Pleth Variability Index, respiration rate, Halo Index</font><font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">TM</sup></font> <font style="FONT-FAMILY: Times New Roman" size="2">and In Vivo Adjustment</font><font style="FONT-FAMILY: Times New Roman" size="1"><sup style="POSITION: relative; BOTTOM: 0.8ex; VERTICAL-ALIGN: baseline">TM</sup></font><font style="FONT-FAMILY: Times New Roman" size="2">. The Company develops, manufactures and markets a family of patient monitoring solutions which incorporate a monitor or circuit board and sensors, including proprietary single-patient use, reusable and resposable sensors and cables. The Company considers the pulse oximetry device (monitor or circuit board), its sensors and cables and software fees to be products as defined in its condensed consolidated statements of comprehensive income. The Company sells to hospitals and the alternate care market through its direct sales force and distributors, and markets its circuit boards containing the Company&#x2019;s proprietary algorithm and software architecture to original equipment manufacturer, or OEM, partners.</font></p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1512000 shares
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.03 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
19.79
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
20.74
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
767000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32403000
us-gaap Fiscal Period
FiscalPeriod
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Fiscal Periods</i></b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">The Company follows a conventional 52/53 week fiscal year. Under a conventional 52/53 week fiscal year, a 52 week year includes four quarters of 13 fiscal weeks while a 53 week fiscal year includes three 13 fiscal week quarters and one 14 fiscal week quarter. Fiscal 2012 was on a 52 week fiscal calendar in which the Company&#x2019;s first, second and third quarters ended on Saturday March&#xA0;31, 2012,&#xA0;June&#xA0;30, 2012 and September&#xA0;29, 2012, respectively, and its fiscal year ended on Saturday, December&#xA0;29, 2012. Fiscal 2013 is also on a 52 week fiscal calendar in which the Company&#x2019;s first and second quarters ended on Saturday, March&#xA0;30, 2013 and June&#xA0;29, 2013, respectively, the third quarter will end on Saturday September&#xA0;28, 2013, and its fiscal year will end on Saturday, December&#xA0;28, 2013.</font></p> </div>
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.41
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P6Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.396 pure
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
1280000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56840000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007 pure
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
166000 shares
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
447000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000000 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Use of Estimates</i></b></font></p> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">The Company prepares its financial statements in conformity with GAAP, which requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include: determination of accounts receivable allowances, inventory reserves, warranty reserves, rebate reserves, valuation of the Company&#x2019;s stock options, distributor channel inventory, royalty revenues, deferred revenue, uncertain income tax positions and the medical device excise tax. Actual results could differ from those estimates.</font></p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.016 pure
us-gaap Revenues
Revenues
273364000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32807000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
5718000
us-gaap Gross Profit
GrossProfit
180813000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-78000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
258203000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
96000
us-gaap Profit Loss
ProfitLoss
31050000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1160000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-504000
us-gaap Operating Income Loss
OperatingIncomeLoss
46321000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2154000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4475000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
43757000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-659000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-569000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2564000
us-gaap Net Income Loss
NetIncomeLoss
33466000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8976000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
92551000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1687000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19800000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19790000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3936000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2416000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-793000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19493000
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2000000
us-gaap Inventory Write Down
InventoryWriteDown
556000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2600000
us-gaap Share Based Compensation
ShareBasedCompensation
6390000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
314000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6519000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
800000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2003000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1261000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4644000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6090000
us-gaap Product Warranty Expense
ProductWarrantyExpense
1205000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28046000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
231000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
897000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5600000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-504000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6400000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2600000
us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
100000
us-gaap Operating Expenses
OperatingExpenses
134492000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106446000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12707000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-301000
masi Long Term Sales Agreement Warranty Maximum
LongTermSalesAgreementWarrantyMaximum
P6Y
masi Initial Term Of Executive Employment Agreement
InitialTermOfExecutiveEmploymentAgreement
P3Y
masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.11 pure
masi Income Tax Benefit From Exercise Of Stock Options Granted
IncomeTaxBenefitFromExerciseOfStockOptionsGranted
436000
masi Rate Of Royalty Agreed To Be Paid
RateOfRoyaltyAgreedToBePaid
0.0775 pure
masi Royalty
Royalty
15161000
masi Percentage Of Accounts Receivable Balance From One Just In Time Distributor
PercentageOfAccountsReceivableBalanceFromOneJustInTimeDistributor
0.08 pure
masi Cash Equivalents Maximum Maturity Period
CashEquivalentsMaximumMaturityPeriod
Three months or less
masi Number Of Days After Which Royalty Report And Payment Is Received
NumberOfDaysAfterWhichRoyaltyReportAndPaymentIsReceived
P60D
masi Long Term Sales Agreement Warranty Minimum
LongTermSalesAgreementWarrantyMinimum
P3Y
masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.13 pure
masi Increase Decrease In Royalties Receivable
IncreaseDecreaseInRoyaltiesReceivable
-130000
masi Percentage Of Executive Officers Unvested And Outstanding Stock Options
PercentageOfExecutiveOfficersUnvestedAndOutstandingStockOptions
0.50 pure
masi Percentage Of Accounts Receivable Balance From One Other Just In Time Distributor
PercentageOfAccountsReceivableBalanceFromOneOtherJustInTimeDistributor
0.05 pure
CY2012 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
200000 shares
CY2012 masi Percentage Of Shares Outstanding
PercentageOfSharesOutstanding
0.03 pure
CY2012 masi Percentage Of Accounts Receivable Balance From One Just In Time Distributor
PercentageOfAccountsReceivableBalanceFromOneJustInTimeDistributor
0.07 pure
CY2012 masi Percentage Of Accounts Receivable Balance From One Other Just In Time Distributor
PercentageOfAccountsReceivableBalanceFromOneOtherJustInTimeDistributor
0.07 pure
CY2011 masi Percentage Of Shares Outstanding
PercentageOfSharesOutstanding
0.03 pure
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.373 pure
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58084000 shares
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.200 pure
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2012Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
23.54
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
943000 shares
CY2012Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
300000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.66
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.383 pure
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57141000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.008 pure
CY2012Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00 pure
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
18053000
CY2012Q2 us-gaap Gross Profit
GrossProfit
81432000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
115317000
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6400000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.013 pure
CY2012Q2 us-gaap Revenues
Revenues
122775000
CY2012Q2 us-gaap Profit Loss
ProfitLoss
17768000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22673000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
22211000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
356000
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-462000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
17697000
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
71000
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
41343000
CY2012Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5100000
CY2012Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
300000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11110000
CY2012Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4000000
CY2012Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1100000
CY2012Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
100000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
58759000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47649000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4443000
CY2012Q2 masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.12 pure
CY2012Q2 masi Royalty
Royalty
7458000
CY2012Q2 masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.14 pure
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.362 pure
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57204000 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.362 pure
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2013Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
19.85
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
764000 shares
CY2013Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
200000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.61
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.377 pure
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56440000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.007 pure
CY2013Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1.00 pure
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7400000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.016 pure
CY2013Q2 us-gaap Revenues
Revenues
137422000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16226000
CY2013Q2 us-gaap Gross Profit
GrossProfit
91232000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
129568000
CY2013Q2 us-gaap Profit Loss
ProfitLoss
14648000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
23180000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
22942000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-812000
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-238000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
17038000
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2390000
CY2013Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2000000
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
46190000
CY2013Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4400000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000
CY2013Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13879000
CY2013Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3000000
CY2013Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1300000
CY2013Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
100000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
68052000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54173000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8294000
CY2013Q2 masi Percentage Of Revenue Two Customer
PercentageOfRevenueTwoCustomer
0.10 pure
CY2013Q2 masi Royalty
Royalty
7854000
CY2013Q2 masi Percentage Of Revenue One Customer
PercentageOfRevenueOneCustomer
0.13 pure

Files In Submission

Name View Source Status
0001193125-13-313110-index-headers.html Edgar Link pending
0001193125-13-313110-index.html Edgar Link pending
0001193125-13-313110.txt Edgar Link pending
0001193125-13-313110-xbrl.zip Edgar Link pending
d558402d10q.htm Edgar Link pending
d558402dex101.htm Edgar Link pending
d558402dex121.htm Edgar Link pending
d558402dex311.htm Edgar Link pending
d558402dex312.htm Edgar Link pending
d558402dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
masi-20130629.xml Edgar Link completed
masi-20130629.xsd Edgar Link pending
masi-20130629_cal.xml Edgar Link unprocessable
masi-20130629_def.xml Edgar Link unprocessable
masi-20130629_lab.xml Edgar Link unprocessable
masi-20130629_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending